share_log

Sipai Health Technology Co., Ltd.'s (HKG:314) Market Cap Surged HK$603m Last Week, Retail Investors Who Have a Lot Riding on the Company Were Rewarded

Sipai Health Technology Co., Ltd.'s (HKG:314) Market Cap Surged HK$603m Last Week, Retail Investors Who Have a Lot Riding on the Company Were Rewarded

思派健康科技有限公司(HKG:314)的市值上週暴漲了60300萬港元,對公司寄予厚望的散戶投資者得到了回報
Simply Wall St ·  09/30 18:35

Key Insights

主要見解

  • Significant control over Sipai Health Technology by retail investors implies that the general public has more power to influence management and governance-related decisions
  • A total of 5 investors have a majority stake in the company with 53% ownership
  • Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock
  • 零售投資者對思派健康科技的重大控制意味着普通公衆擁有更多影響管理和治理決策的權力
  • 公司總股份的53%由5位投資者持有。
  • 所有權研究結合過去的表現數據可以幫助更好地理解股票的機會。

Every investor in Sipai Health Technology Co., Ltd. (HKG:314) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 40% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

思派健康科技有限公司(HKG:314)的每位投資者都應該了解最有影響力的股東群體。我們可以看到,零售投資者擁有該公司40%的股權,換句話說,該群體面臨的上行潛力(或下行風險)最大。

As a result, retail investors were the biggest beneficiaries of last week's 14% gain.

因此,零售投資者成爲上週14%漲幅的最大受益者。

In the chart below, we zoom in on the different ownership groups of Sipai Health Technology.

在下面的圖表中,我們將聚焦思派健康科技的不同持有者群體。

big
SEHK:314 Ownership Breakdown September 30th 2024
SEHK:314 所有權分佈2024年9月30日

What Does The Institutional Ownership Tell Us About Sipai Health Technology?

機構持股告訴我們關於思派健康科技的什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。

We can see that Sipai Health Technology does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Sipai Health Technology's historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到思派健康科技確實有機構投資者;他們持有公司的相當一部分股票。這意味着爲這些機構工作的分析師已經研究了這支股票,且他們對其感興趣。但和其他任何人一樣,他們也可能犯錯。當多家機構持有一支股票時,總會存在它們陷入『擁擠交易』的風險。一旦這種交易失敗,多方可能會競相快速賣出股票。這種風險在一家沒有增長曆史的公司中更高。您可以查看思派健康科技的歷史收益和營業收入,但請記住故事往往更加複雜。

big
SEHK:314 Earnings and Revenue Growth September 30th 2024
SEHK:314於2024年9月30日的收益和營業收入增長

Sipai Health Technology is not owned by hedge funds. Tencent Holdings Limited is currently the company's largest shareholder with 27% of shares outstanding. The second and third largest shareholders are Fidelity International Ltd and Xuguang Ma, with an equal amount of shares to their name at 7.5%. Xuguang Ma, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board.

思派健康科技不是由對沖基金擁有。騰訊控股有限公司目前是該公司最大的股東,持有27%的股份。第二和第三大股東分別是富達國際有限公司和徐光馬,他們的股份持有量相等,爲7.5%。徐光馬是第三大股東,同時也擔任董事會主席。

On looking further, we found that 53% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

進一步觀察,思派健康技術的前五大股東持有53%的股份。換句話說,這些股東在公司的決策中擁有重要的發言權。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

雖然研究公司的機構持股可以增加您的研究價值,但研究分析師的建議以加深對股票預期表現的全面了解也是一個好習慣。雖然有部分分析師的覆蓋,但該公司可能沒有受到廣泛的關注。因此,在未來可能會受到更多關注。

Insider Ownership Of Sipai Health Technology

思派健康科技的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

雖然「內部人士」的明確定義具有主觀性,但幾乎所有人都認爲董事會成員是內部人士。公司管理業務,但首席執行官即使是董事會成員,也要向董事會負責。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

We can see that insiders own shares in Sipai Health Technology Co., Ltd.. As individuals, the insiders collectively own HK$357m worth of the HK$4.8b company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.

我們可以看到,思派健康科技股份有限公司的股東們持有股份。作爲個人,這些內部人士共同持有價值35700萬港元的48億港元公司。看到內部人士有一些投資是好事,但值得注意的是他們是否一直在買入。

General Public Ownership

一般大衆所有權

With a 40% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Sipai Health Technology. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

作爲擁有40%股權的一般公衆,主要由個人投資者組成,對思派健康科技有一定的影響力。雖然這種所有權比例可能還不足以影響公司政策決定的結果,他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With an ownership of 11%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

私募股權公司持有11%的股份,有望在價值創造方面發揮一定的作用。有時候我們看到私募股權公司會長揸一份股權,但一般來說,他們的投資週期比較短,就如其名稱所示,他們很少在上市公司進行投資。過一段時間後,他們可能會尋找賣出股份,將資本重新配置到其他項目上。

Private Company Ownership

私有公司的所有權

We can see that Private Companies own 5.2%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們可以看到,私營公司持有已發行股份的5.2%。或許值得進一步深入了解。如果相關方,如內部人員,對其中一傢俬營公司有興趣,那應該在年度報告中披露。私營公司也可能對該公司有戰略利益。

Public Company Ownership

上市公司所有權

We can see that public companies hold 27% of the Sipai Health Technology shares on issue. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership.

我們可以看到,上市公司持有思派健康科技股份已發行股份的27%。很難確定,但這表明它們可能存在交織的業務利益。這可能是一種戰略利益,所以值得關注這一領域的所有權變化。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我覺得查看公司的實際所有者非常有趣。但爲了真正獲得洞察力,我們需要考慮其他信息。

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

我總是喜歡查看營業收入增長的歷史記錄,你也可以免費訪問這個詳細圖表中的歷史營收和收益圖表。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果您像我一樣,可能希望考慮這家公司是否會增長或縮小。幸運的是,您可以查看此免費報告,顯示分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論